Saphenous vein grafts (SVGs) remain the most frequently used conduits in coronary artery
bypass graft surgery (CABG). Despite advances in surgical techniques and …

Coronary artery bypass grafting (CABG) remains a vital treatment for patients with
multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the …

OBJECTIVES The purpose of this study was to examine the long-term clinical outcome after
percutaneous intervention of saphenous vein grafts (SVG) and to identify the predictors of …

Saphenous vein graft (SVG) disease after coronary artery bypass grafting (CABG) occurs in
three phases: thrombosis, intimal hyperplasia, and atherosclerosis. Within the first month …

Up to 20% of saphenous vein grafts (SVGs) fail within 2 years of coronary artery bypass
grafting (CABG). The long-term effects of early SVG failure on major clinical events remain …

Objective: To review our current understanding of the epidemiology and pathogenesis of
vein graft failure (VGF), give an overview of current preventive and interventional measures …

Myocardial ischaemia resulting from obstructive coronary artery disease is a major cause of
morbidity and mortality in the developed world. Coronary artery bypass graft (CABG) surgery …

Background—Treatment of saphenous vein graft (SVG) stenosis with percutaneous
coronary intervention has a 15% to 20% incidence of major adverse cardiac events (MACE) …

The choice of the graft conduit is crucial to the success of coronary artery bypass grafting
(CABG) because the patency of a coronary conduit is closely associated with an uneventful …

Saphenous vein grafts are commonly used conduits for surgical revascularization of
coronary arteries but are associated with poor long-term patency rates. Percutaneous …